Has Kelly London received payments from drug or device companies?

Yes. Drug and device makers reported $9,800 in general payments to Kelly London across 441 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kelly London did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kelly London come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kelly London

Psychiatric/Mental Health · Arlington, VANPI 1376913178

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 441 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 53 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $4,105 and has fallen 85.7% since, to $588 in 2025. Among psychiatric/mental health clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,800in general payments, 2019–2025

Across 441 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Lilly USA, LLC$1K
Lundbeck LLC$619
Biogen$464
Novartis$315
Teva Pharmaceuticals USA, Inc.$291
plus $5K from 47 others

What the payments were for

Food & beverage$9,800100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	98	$2,176
Lilly USA, LLC	51	$1,107
Lundbeck LLC	25	$619
Biogen	20	$464
Novartis	16	$315
Teva Pharmaceuticals USA, Inc.	16	$291
UCB, Inc.	12	$286
Biohaven Pharmaceutical Holding Company Ltd.	9	$281
Harmony Biosciences LLC	11	$269
Amneal Pharmaceuticals LLC	10	$237
Amgen(2 entities)	11	$235
Impel Pharmaceuticals Inc.	12	$232
Neurocrine Biosciences, Inc.	8	$213
Axsome Therapeutics, Inc.	7	$208
Argenx US, Inc.	5	$202
TG Therapeutics, Inc.	2	$195
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$188
Eisai Inc.	9	$179
Pfizer	7	$167
Idorsia Pharmaceuticals US Inc	9	$156
EMD Serono, Inc.	7	$156
Neurelis, Inc.	9	$153
Otsuka America Pharmaceutical, Inc.	7	$146
Kyowa Kirin, Inc.	6	$125
GE HealthCare	4	$113
Jazz Pharmaceuticals Inc.	4	$97
Sumitomo Pharma America, Inc.	5	$83
Azurity Pharmaceuticals, Inc.	4	$78
AstraZeneca	3	$73
Takeda Pharmaceuticals U.S.A., Inc.	3	$72
Bausch Health US, LLC	4	$72
Upsher-smith Laboratories LLC	3	$58
Corium, LLC	5	$50
Vanda Pharmaceuticals Inc.	2	$43
Bristol Myers Squibb	2	$40
Tris Pharma Inc	2	$38
Merz Pharmaceuticals, LLC	2	$34
Avion Pharmaceuticals	2	$34
Avanir Pharmaceuticals, Inc.	2	$29
Currax Pharmaceuticals LLC	2	$26
Sunovion Pharmaceuticals Inc.	1	$24
Genentech USA, Inc.	3	$23
Dynasplint Systems Inc.	1	$23
Vertical Pharmaceuticals, LLC	1	$22
Grifols USA, LLC	1	$22
Impel Pharmaceuticals LLC	1	$22
Acorda Therapeutics, Inc	1	$21
Averitas Pharma Inc.	1	$21
Tanabe Pharma America, Inc.	1	$20
Octapharma USA, Inc.	1	$19
Si-bone, Inc.	1	$19
Supernus Pharmaceuticals, Inc.	1	$15
Life Molecular Imaging Ltd	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,800 in reported general payments places this provider in the 95th percentile of 1,003 psychiatric/mental health providers in Virginia.

See all psychiatric/mental health providers in Virginia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Rivastigmine	11	$3,680
Memantine Hcl	35	$1,514
Gabapentin	36	$831
Donepezil Hcl	44	$776
Levetiracetam	13	$484
Propranolol Hcl ErPropranolol Hcl	13	$366
Mirtazapine	17	$265
Escitalopram Oxalate	14	$83
Quetiapine Fumarate	11	$47

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Arlington

Jing CastroArlington$15K
Justin RayChesapeake$127K
Katia HallChesapeake$88K
Christine GilmoreBedford$75K
Sarah FaberNewport News$59K
Kristine GarciaGlen Allen$46K
Tonjanika BoydRichmond$40K
Kirby PatmonRichmond$36K
Juliana FroschAmherst$36K
Derick ReedyNickelsville$23K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →